Intravenous C-type natriuretic peptide augments behavioral and endocrine 
effects of cholecystokinin tetrapeptide in healthy men

Kellner, M; Yassouridis, A; Hua, Y; Wendrich, M; Jahn, H; Wiedemann, K

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Intravenous C-type natriuretic peptide augments behavioral and endocrine effects of cholecystokinin tetrapeptide in healthy men

MPS-Authors

Kellner, M
Max Planck Institute of Psychiatry, Max Planck Society;

Yassouridis, A
Max Planck Institute of Psychiatry, Max Planck Society;

Hua, Y
Max Planck Institute of Psychiatry, Max Planck Society;

Wendrich, M
Max Planck Institute of Psychiatry, Max Planck Society;

Jahn, H
Max Planck Institute of Psychiatry, Max Planck Society;

Wiedemann, K
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Kellner, M., Yassouridis, A., Hua, Y., Wendrich, M., Jahn, H., & Wiedemann, K. (2002). Intravenous C-type natriuretic peptide augments behavioral and endocrine effects of cholecystokinin tetrapeptide in healthy men. Journal of Psychiatric Research, 36(1), 1-6.

引用: https://hdl.handle.net/11858/00-001M-0000-000E-A267-0

要旨

Given the anxiogenic effects of the type-B natriuretic peptide receptor agonist C-type natriuretic peptide (CNP) in rodents. we investigated the influence of CNP pretreatment upon the behavioral and endocrine action of the panicogen cholecystokinin tetrapeptide (CCK-4) in healthy men. In a randomized double-blind balanced design, 20 male volunteers were given an intravenous infusion of 300 mug of CNP vs. placebo followed by 25 mug of CCK-4. The behavior was assessed using panic, anxiety, and dissociation questionaires before the infusion and after the CCK-4 stimulus. Furthermore, the stress- sensitive hormones adrenocorticotropic hormone (ACTH), cortisol, and prolactin were measured. CNP pretreatment enhanced the anxiogenic and prodissociative effects of CCK-4 and significantly augmented the ACTH surge after CCK-4. However, no effect of CNP was seen upon panic symptoms. Our preliminary data support a role of type-B natriuretic peptide receptors in anxiety modulation in normal man. (C) 2002 Elsevier Science Ltd. All rights reserve